On February 20, 2016, the FDA held a workshop on potential regulation of NGS tumor panels. FDA website here. The FDA immediately posted a webcast (see website) and a 200 slide consolidated deck (at website or here).
New March 29: An unofficial transcript of the meeting, based on the archived webcast, is in the cloud, here.
FDA and Liquid Biopsy? Note that on page 5, Reena Phillips of FDA (division director for genetics and molecular pathology) says that on "July 19" there will be a workshop on NGS and liquid biopsy. That workshop has been posted here and will be co sponsored by the American Association for Cancer Research.
Additional Links. For additional links such as trade journals, see my original blog for the workshop, here.
Short link: tinyurl.com/fda20160220